HUTCHMED (China) Ltd (HKSE:00013)
HK$ 26.85 -0.35 (-1.29%) Market Cap: 23.27 Bil Enterprise Value: 17.96 Bil PE Ratio: 0 PB Ratio: 4.07 GF Score: 77/100

Full Year 2019 Hutchison China MediTech Ltd Earnings Call Transcript

Mar 03, 2020 / 01:00PM GMT
Operator

Ladies and gentlemen, welcome to the Chi-Med 2019 Full Year Financial Results. My name is Maxine, and I will be coordinating your call today. (Operator Instructions)

I will now hand you over to your host, Mr. Christian Hogg, to begin. Christian, please go ahead when you're ready.

Christian Lawrence Hogg;China;Limited;Former CEO;Executive Director
HUTCHMED

()-&

Thank you, Maxine. Welcome, everybody, to the Chi-Med 2019 results presentation. It's an hour-long session today. I'm going to try and complete the presentation in maybe 35, 40 minutes, and then leave 20, 25 minutes at the end for Q&A.

So if we go to Page #3 of the presentation. You can see we've made a lot of progress in 2019 towards our aim of building a global science-focused biopharmaceutical company from our established base in China. On the global innovation side, our team is now over 500 people, scientific team on the ground, in China. We've built and continue to build a global development infrastructure. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot